Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phaseIIstudy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phaseIIstudy

Published:2018-09-25 Issue:11 Volume:109 Page:3554-3563
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ohnuma Hiroyuki¹^ORCID,Sato Yasushi²,Hayasaka Naotaka¹,Matsuno Teppei¹,Fujita Chisa¹,Sato Masanori¹,Osuga Takahiro¹,Hirakawa Masahiro¹,Miyanishi Koji¹,Sagawa Tamotsu³,Fujikawa Koshi³,Ohi Motoh⁴,Okagawa Yutaka⁵,Tsuji Yasushi⁶,Hirayama Michiaki⁵,Ito Tatsuya⁷,Nobuoka Takayuki⁷,Takemasa Ichiro⁷,Kobune Masayoshi⁸,Kato Junji¹

Affiliation:

1. Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan

2. Department of Community Medicine for Gastroenterology and Oncology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan

3. Department of Gastroenterology Hokkaido Cancer Center Sapporo Japan

4. Division of Gastroenterology Sapporo Kyoritsu Gorinbashi Hospital Sapporo Japan

5. Department of Gastroenterology Tonan Hospital Sapporo Japan

6. Department of Medical Oncology Tonan Hospital Sapporo Japan

7. Department of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo Japan

8. Department of Hematology Sapporo Medical University School of Medicine Sapporo Japan

Funder

Alexion Pharmaceuticals

Astellas Pharma

Eisai

Otsuka Pharmaceutical

Kyowa Hakko Kirin

Shionogi

Daiichi-Sankyo

Taiho Pharmaceutical

Chugai Pharmaceutical

Pfizer Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13772

Reference48 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

3. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

4. Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204

5. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma;International Immunopharmacology;2024-12

2. Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation;Biomedicine & Pharmacotherapy;2024-10

3. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18

4. Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis;Cancer Medicine;2024-02

5. Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer;Journal of Clinical Medicine;2023-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3